Bioactivity of collagen peptides derived from commercial animals: In silico investigation
Pepsin
Dipeptidyl peptidase
Oligopeptide
DOI:
10.1016/j.lwt.2023.115381
Publication Date:
2023-10-03T06:33:02Z
AUTHORS (9)
ABSTRACT
Collagen peptides (CP) obtained from collagen hydrolysis have drawn much attention for their broad bioactivities, such as antioxidant, anti-inflammatory, angiotensin-converting enzyme (ACE) and dipeptidyl peptidase-IV (DPP-IV) inhibitory activities. This study employed an in silico approach to investigate the bioactivities of CP fish, chicken, cattle, pig, yak, sheep, donkey. BLAST analysis amino acid sequences showed mammals had comparable but those fish chicken possessed different bioactivity potential due low protein homology. In with gastrointestinal enzymes, including trypsin, pepsin, proteinase K that number bioactive (922) (737–905) was higher than (544–675) because lower content proline collagen, amount percentage total generated tilapia highest (86.4%). The most common were ACE DPP-IV A molecular docking Thr-Phe Gly-Phe strongest binding energy enzymes involved DPP-IV, respectively, indicating a good source anti-hypotensive anti-hypoglycaemic peptides.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (44)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....